ABSTRACT: Osteoporotic bone fractures are highly prevalent and involve lengthy recovery. Lithium, commonly used in psychiatric medicine, inhibits glycogen synthase kinase-3b in the Wnt/b-catenin pathway, leading to up-regulation of osteogenesis. Our recent preclinical work demonstrated that a 20 mg/kg lithium dose administered beginning 7 days post-fracture for 14 days optimally improved femoral fracture healing in healthy rats at 4 weeks post fracture (46% higher torsional strength). In this study, lithium treatment was evaluated for healing of osteoporotic bone fractures. Six-month-old ovariectomized rats were subjected to closed, loaddrop induced femoral diaphyseal fracture. Two regimens involving treatment initiation on day 7 and day 10, respectively, 20 mg/kg/day oral dose and 14 days duration were evaluated. Femurs of lithium-vs. saline-treated rats were analyzed at 4 weeks (for day 7 onset regimen) or 6 weeks (for day 10 onset regimen) post-fracture by stereology and torsional mechanical testing. Initiation on day 10 led to a significant 50% higher maximum yield torque (primary outcome measure) at 6 weeks (309 vs. 206 N-mm, p ¼ 0.005; n ¼ 7, 7). Initiation on day 7 suggested a trend toward a more modest improvement in maximum yield torque (13%) evaluated at 4 weeks postfracture (234 vs. 206 N-mm, p ¼ 0.10; n ¼ 10, 13). Qualitatively, lithium-treated femurs demonstrated better periosteal and mineralized callus bridging in the day 10 initiation group. Lithium is a widely-available, orally administered, low-cost drug, which represents a feasible pharmacological intervention for both healthy and osteoporotic fracture healing. This study provides important guidelines for future clinical evaluation of lithium in osteoporotic fracture patients. Osteoporotic fractures are debilitating injuries affecting 40-50% of all women and 13-22% of all men above the age of 50.
Osteoporotic fractures are debilitating injuries affecting 40-50% of all women and 13-22% of all men above the age of 50. 1 Timely and reliable fracture healing is critical in patients with osteoporosis to improve early mobility, decrease recurrent fracture risk, and reduce the ensuing socioeconomic burden that adversely affects our patients and the health care system. Recovery is often prolonged and complex in these patients due to higher risks of post-surgical complications, implant failures, and medical comorbidities. 2 Even in those osteoporotic fractures that progress to heal, the time to achieve union may be longer due to impaired bone biology and poor healing response. 2, 3 The canonical Wingless (Wnt) pathway has been identified as a potential target for augmenting fracture healing. Wnt molecules inhibit glycogen synthase kinase-3b (GSK-3b), thereby preventing the phosphorylation of b-catenin and promoting transcription of osteogenic genes. During fracture healing, Wnt signaling peaks when the soft chondrocyte-rich callus transitions to an osteoblast-rich mineralized matrix. As such, up-regulation of the Wnt pathway presents a strategy for improving endochondral ossification. Lithium is a known GSK-3b inhibitor that promotes b-catenin expression in the canonical Wnt pathway. 4 Lithium has been shown to have an anabolic effect on bone, increasing osteoblastic differentiation and proliferation to improving fracture callus formation. 5 However, the impact of lithium in fracture healing is highly dependent on its administration parameters, particularly the timing of treatment initiation (onset). 6 It is anabolic only after mesenchymal stem cells have committed to an osteoblastic lineage. 7 As such, lithium administration must occur as the soft callus transitions to woven bone. In our previous work, we delineated the optimal lithium administration conditions (dose, duration, and initiation time) in a healthy rat femoral fracture model. Daily oral gavage of 20 mg/kg lithium for 2 weeks beginning 7 days post-fracture was shown to significantly improve the biomechanical strength of healing femora at 4 weeks ($1.5-fold higher maximum yield torque). 6 This treatment period corresponded with the phase of callus transition in the reparative stage of healing. 8 While, a precise timeline documenting delays in fracture healing is not well established for osteoporotic rodents, a later soft to hard callus transition could influence the impact of lithium's potential in osteoporotic fractures. 2, 3 The purpose of this study was to evaluate the benefits of lithium in osteoporotic bone fracture healing. It is hypothesized that oral lithium treatment with a delayed initiation time is required to positively impact the impaired healing of osteoporotic femoral fractures.
METHODS

Animal Model
All animal experiments were approved by our institutional Animal Care Committee. Female Sprague Dawley rats were bilaterally ovariectomized at 3 months (Taconic Laboratories. NY) and subsequently housed for an additional 3 months (12-h day/night cycle, water and food ad libitum) to establish a standard post-menopausal bone loss rodent model. The rats weighed 330-400 g on the day of fracture. The femur was pre-stabilized with an intramedullary pin and its position was verified radiographically with an intraoperative large C-arm X-ray. A closed, right femoral diaphyseal fracture was created using a load-drop apparatus (loads were varied: 250-300 g, based on animal weight). 6 Rats with extensive fragmentation, considerable displacement of bone fragments leading to significant limb shortening, extramedullary pin positioning, open fractures, and non-diaphyseal fractures were excluded from the study.
Treatment
Two regimens, differing only in their treatment initiation times, days 7 and 10, were evaluated (Fig. 1) . Day 7 corresponded to the optimal time for the initiation of lithium administration in the healthy rat fracture model, demonstrating significantly better healing than lithium initiation on day 3 6 and days 10 and 14. 9 The importance of precise timing with respect to treatment initiation motivated consideration of the second regimen, with a delay in initiation to day 10, in order to compensate for the potential of slower early healing (i.e., soft callus formation) under osteoporotic conditions. Both regimens involved daily oral gavage of 20 mg/kg lithium chloride for 2 weeks. Their respective control groups received a volumetric equivalent of 0.9% NaCl during the treatment period. Rats on the established day 7 onset regimen were sacrificed at 4 weeks post-fracture as per previous study protocol. 6 Those on the day 10 onset regimen were sacrificed at 6 weeks post-fracture to enable longer assessment of the fracture healing progression. All femurs were harvested, wrapped in saline-soaked gauze, and stored at À20˚C until evaluation.
Micro-CT-Based Stereology
Harvested femurs were thawed at 4˚C for 24 h prior to imaging. Femurs were vertically aligned and scanned at 14.8 mm isotropic voxel size using energy settings of 55 kV, 200 mA, and beam hardening correction factor of 1,200 mg hydroxyapatite (mgHA) per cm 3 (mCT 100 scanner, Scanco Medical, Brϋttisellen, Switzerland). Reconstructed scans were exported as DICOM images and processed in Amira-DEV 5.3.3 (Visualization Sciences Group, FEI). The scans were cropped to a region extending from mid-way through lesser trochanter to the peak of the patellar notch. An intensity-based minimum threshold value of 365 mgHA/cm 3 was applied to remove unmineralized callus, leaving a region of interest (ROI) containing mineralized callus and original cortical bone. Standard stereologic measures of bone volume (BV), total volume (TV), bone volume fraction (BV/TV), bone mineral density (BMD), tissue mineral density (TMD), and bone mineral content (BMC) were computed using CT Analyser software (SkyScan, Kontich, Belgium).
Further analysis of the day 10 onset regimen groups was performed on a smaller ROI of 1,000 axial slices bounding the fracture to focus on the callus stereology alone. This region generally contained all of the callus (based on the AP view). Both unmineralized callus and original cortical bone were segmented out using minimum and maximum threshold values of 365 and 920 mgHA/cm 3 , respectively, and the stereologic analyses repeated.
Radiographic Union Scoring
Anterior-posterior and lateral digitally reconstructed radiographs (DRR) of the rat femora treated at day 10 onset were generated from the acquired mCT volumes using Siddon's ray-tracing algorithm, and a linear attenuation model with thresholding. 10 The DRRs were generated with a resolution of 1,024 Â 764 pixels, using a simulated sourceimage distance of 20 cm and an isotropic pixel spacing of 14.8 mm. The software code for calculating the DRRs was implemented using the Nvidia CUDA 1 GPGPU parallel computing framework.
Radiographs were scored by a senior orthopaedic trauma surgeon using a validated radiographic union scale in tibial (RUST) fractures. 11 For each femur, the four cortices in two orthogonal views were individually graded on a scale of 1-3, yielding a total score of 4-12. At each of the four projected cortices, no callus and a visible fracture line received a score of 1, visible callus and visible fracture line received a score of 2, and bridged callus and no fracture line received a score of three. A RUST score of 10 is considered clinically united in human tibia that have undergone intra-medullary nailing. 12 
Biomechanical Testing
Femurs were tested under torsional loading applied at a rate of 1.5˚/second until complete failure or until a maximum twist of 50˚was reached (Bionix 858, MTS Systems, Eden Prairie, MN). Yield point was identified in the resulting load deformation curve, and its torque load and angle were defined as the maximum yield torque and twist angle at failure, respectively. Torsional stiffness was calculated as the linear slope of the elastic region.
Statistical Analysis
Mean values were compared between the lithium treated groups and their respective saline treated control groups for each outcome measure using unpaired Student's t-test (SPSS V18, IBM, IL). One-way ANOVA with Tukey's post hoc analysis was used to compare the primary outcome measure maximum yield torque for the four treatment groups. Correlations between biomechanical strength and stereological measures were evaluated by Pearson analysis using results of both groups of day 10 onset regimen. In addition, for the day 10 onset regimen, each lithium treated femur was paired with a control treated femur based on the fracture pattern and fragmentation seen in mCT scans (Fig. 3) . Pairwise comparison of their callus stereology and RUST scores was performed using a paired t-test and signed-rank test, respectively. For all analyses, p < 0.05 was considered significant. 
RESULTS
Ovariectomy-induced osteoporosis was evident by the end of the housing period. The rats had gained significant weight ($40%) due to estrogen deficiency. During fracture creation, the intramedullary pin could be inserted retrograde into the femur through a capacious intramedullary canal and engaged at the proximal end of the femur manually. In contrast, in healthy bone, the pin had to be power drilled into the canal and purchased at the proximal end. The mCT scans of harvested femurs (at 1 month post-fracture) had visibly diminished trabecular network in the metaphysis.
A total of 44 rats underwent the fracture experiment. Five rats were sacrificed within 2 days post fracture due to extensive comminution and/or shortening. The remaining rats tolerated their fractures well otherwise and were permitted to weight bear immediately. Two additional rats were excluded from analysis due to comminution of the fracture ultimately leading to early limb shortening.
Treatment Initiation on Day 7 Did Not Significantly Improve Healing by 4 Weeks
While there was no significant improvement in osteoporotic fracture healing at 4 weeks post-fracture, the lithium group (n ¼ 10) demonstrated a trend toward a higher average maximum yield torque compared to control (n ¼ 13) (13%, p ¼ 0.10; Fig. 2 ). The two groups had similar twist angle at failure and torsional stiffness ( Treatment Initiation on Day 10 Significantly Improved Healing at 6 Weeks Average maximum yield torque was 50% higher for the lithium group (n ¼ 7) compared to control (n ¼ 7) at 6 weeks post fracture (309.4 AE 57.3 vs. 209.4 AE 54.9 N-mm, p ¼ 0.005; Fig. 2) . Twist angle at failure was similar for the two groups ( Table 1) . The lithium group also demonstrated a trend toward a higher torsional stiffness (27%, p ¼ 0.08; Table 1 ).
No differences were observed when comparing the stereology of the whole femoral shaft, which included the callus and the pre-existing cortical bone. However, in the pairwise comparison of the callus stereology alone, the lithium group had lower BV (63.1 vs. 78.6 mm In further qualitative analysis of the mCT scans, callus was seen either completely or at least predominantly in the inter-cortical region in the lithium treated group (Fig. 3B and C) . However, in the control treated group the callus at the fracture gap was primarily external and extended into the inter-cortical region only at some gaps ( Fig. 3E and F) .
Radiographic Scores Did Not Differ Significantly Between Matched Femurs at 6 Weeks
Healing was compared between similarly fractured matched pair femurs under the day 10 onset regimen from DRRs scored using the RUST scale (Fig. 4) . Radiographic union (RUST ! 10) was achieved for 5/7 and 4/7 samples in the day 10 lithium treated and control groups respectively. Pairwise comparison of the composite scores did not yield a statistically Figure 2 . Box whisker plot of maximum yield torque for the four groups comparing lithium and control groups with initiation times at days 7 and 10, respectively. Ã p < 0.05. 
Maximum Yield Torque Was Similar for the Control
Groups at 4 and 6 Weeks Post Fracture ANOVA test for maximum yield torque indicated a significant difference between the groups (p < 0.001). Tukey's analysis found no statistical difference between the two control groups despite their different healing times (4 weeks and 6 weeks post-fracture). Furthermore, the yield torques of the control groups were similar to the day 7 onset lithium regimen. These three groups had significantly lower yield torque than the day 10 onset lithium regimen (p < 0.05). 
DISCUSSION
There is a significant clinical need for new approaches to improve fracture healing in osteoporotic bone. In this study, lithium, a widely used pharmacologic in psychiatric medicine, was assessed for improving endochondral bone healing in osteoporotic fractures. A 20 mg/kg dose given for 2 weeks starting on day 10 post-fracture led to a 1.5-fold increase in maximum yield torque at 6 weeks compared to saline treated controls. In contrast, the lithium administration parameters previously optimized to improve the healing of healthy, nonosteoporotic femoral shaft fractures (i.e., treatment initiation on day 7) failed to significantly augment healing in osteoporotic rats. As such, this work demonstrated that a further delay in lithium initiation time is required to positively impact the impaired bone healing of osteoporotic femoral fractures, leading to similar ($50%) improvement in torsional strength as seen in healthy fracture treatment. At 6 weeks, femurs of the day 10 onset lithium group had smaller calluses with improvement in intercortical bridging and higher torsional load-bearing ability. Torsional stiffness was found to be inversely correlated with BV/TV of the callus, suggesting that smaller calluses were stiffer (pooled data, lithium, and controls). In endochondral healing, the callus attains its peak size prior to hypertrophy of the cartilaginous callus beginning around day 10, followed by a slow subsequent decrease in size. Thus, a smaller callus seen in the lithium treated group at 6 weeks may suggest accelerated bone remodeling and maturation progression through the stages of hard callus formation, despite the impaired healing conditions in osteoporotic bone. Accompanied with increased failure strength, this scenario parallels the desired course of uneventful fracture healing. As well, in contrast to osteotomy or gap fracture models, the callus in these traumatic fragmentary fractures is filled with old bone fragments, mineralized and unmineralized callus. It is the connectivity of the bone as a whole that gives the construct its mechanical strength. 13 The lack of positive correlation between traditional stereological parameters (BMD and BV/TV) and torsional strength may be explained by improved bone tissue connectivity. In the lithium treated group, the mineralized callus seen in the inter-cortical region may provide direct connectivity of the bone through the fracture site, whereas the callus primarily external to intercortical region in the control femora may have led to more limited skeletal connectivity.
As radiographic assessment (X-ray imaging) is the primary clinical measure used in fracture healing, micro-CT scans were converted into clinically equivalent radiographs and scored using the RUST system. The RUST values indicated a 60-70% level of radiographic union in the lithium treated and control groups at 6 weeks. However, the sensitivity of radiographic assessment using DRRs and RUST scoring to improvements in torsional yield strength was limited. This must be considered in evaluating clinical outcome measures evaluating fracture healing in the context of future translational studies.
Rodent models of osteoporosis demonstrate delayed healing of long-bone fractures compared to healthy animals. 14, 15 The timeline of delay is not well characterized. In our findings, there was no significant difference in the maximum yield torque between the 4 and 6 week untreated control groups. As lithium is anabolic only after the mesenchymal stem cells have committed to an osteoblastic lineage, administration must occur as the soft callus transitions to woven LITHIUM IMPROVES OSTEOPOROTIC FRACTURE HEALING bone. 7 The slightly delayed initiation of lithium treatment on day 10 optimally targeted the osteoblastic cell type and captured the desired period of callus transition. Two weeks of treatment was likely sufficient to enhance osteoblastic differentiation and proliferation. Whether the overall process of long-bone fracture healing is delayed in osteoporotic patients is still debated. 3, 7 However, the reduced proliferation and osteogenic differentiability of mesenchymal stem cells may explain the positive impact of delaying the lithium treatment initiation time in the osteoporotic model. These stem cells are crucial during the early reparative phase and lithium's action is mediated via the committed osteoprogenitor cells. 16 The slightly delayed initiation required in osteoporotic rats may bear clinical relevance in considering the future clinical translation of lithium in the treatment of patients with osteoporosis. 17, 18 Previous studies have histologically evaluated the temporal changes in callus composition and the impact of lithium on the callus tissue. 5, 19 In healthy untreated mice, Chen et al. 5 performed histology on days 3, 9 14, 21, 35 post-osteotomy delineating the time point of callus transitioning. At 9 days, the callus was chondrocytic (mature and/or hypertrophic) with some woven bone. At 14 days, it was predominantly hypertrophic cartilage and active osteoblasts in a mineralizing matrix. At 21 days, the callus was bony. Hence, cartilaginous callus likely began to transform slightly before day 9 and was complete $day 21. Upon lithium treatment, initiated either 2 weeks prior to osteotomy or 4 days post-osteotomy, only post-osteotomy treatment led to enhanced healing. Larger mineralized callus was seen in histology, which was confirmed by higher bone density and bone volume fraction in the post-osteotomy treatment group. Prior initiation led to accumulation of undifferentiated mesenchymal cells. Wang et al. 19 showed histologic differences between lithium versus saline treated tibias with distracted osteogenesis at 8 weeks. The bridging callus was composed of woven bone rather than fibrous tissue with better trabecular restoration in the lithium treated tibia.
The current study evaluated lithium based healing in the context of osteoporotic bone for which the impact of lithium (i.e., enhancing endochondral ossification) remains similar. Lithium acts through the canonical Wnt pathway, which is the primary ossification-inducing pathway during callus transition regardless of the bone's pre-fracture quality. Future histologic assessment considering the development of chondrogenic ossification would be interesting to better delineate the timeline of fracture healing in osteoporotic rats, and may give strength to the choice of the day 10 lithium initiation protocol which we have shown to significantly improve fracture healing. Future work could also consider later time points (i.e., 8 weeks or longer post fracture) to characterize the potential impact of lithium on bone remodeling and final strength attained by healed femora.
In recent years, lithium has gained attention as a potential adjunct for bone healing. Lauing et al. 20 treated alcohol-exposed, tibial shaft fractured mice with 100 mg/kg lithium between days 4 and 14. At 14 days, the alcohol þ lithium treated group had restored callus healing similar to healthy mice receiving lithium. Chenet al. 5 treated tibial osteotomy with 200 mg/kg lithium and observed enhanced osteoblastic callus at 21 days in mice treated from 4 days postosteotomy. In another study, distracted osteotomies in rats achieved complete bony restoration after 10 weeks of daily 200 mg/kg lithium. 18 In a recently published paper, Jin et al. 21 reported an anabolic impact of lithium in osseointegration of tibial implants in OVX rats. Stereologic properties of bone adjacent to the implant and the implant push-out strength significantly improved with 150 mg/kg given every 2 days for 3 months compared to a control treated OVX group. In comparison to our lithium treatment regimen, however, these studies involved much higher doses and in some cases much longer treatment durations.
Side effects to lithium treatment have been well documented in the psychiatric literature. 22 To minimize the risk of lithium toxicity, serum levels must be maintained below its safe limit. The daily administration of 20 mg/kg of lithium used in this study translates to a dose representing 25-30% of the minimum prescribed maintenance dose used in psychiatric treatment. 21 Combined with the short 2 week duration of use, the risk of lithium side effects in the context of fracture healing is small. In addition to minimal side-effects, the daily oral regimen is easy to administer with good compliance.
Numerous adjunct strategies which have been explored towards the goal of promoting fracture healing, particularly at the pre-clinical level, have experienced challenges related to administration, applicability, availability, cost, and safety. Biological enhancement with supplements (i.e., tocotrienol/vitamin E), agonistic cytokines (i.e., bone morphogenic proteins (BMPs)), and novel synthetic molecules (i.e., anti-sclerostin antibodies) have shown some promise in osteoporotic fracture models. 23 However, their clinical evaluation and approval can be challenged by insufficient knowledge about pharmacokinetics, safe dosing ranges and optimal administration strategies. The clinical applicability of these strategies may further be limited by patient factors, therapeutic cost and availability, as in case of FDA approved BMP-2 and BMP-7. 23 Commercially available anti-resorptive and osteoinductive therapeutics have been evaluated in osteoporotic patient cohorts with varied success. Lengthy teriparatide treatment reduced the union time for non-operative distal radius and intertrochanteric hip fractures. 24, 25 In contrast, strontium ranelate failed to augment wrist fracture healing in elderly patients. 26 The low cost, widespread availability and well known clinical safety profile of lithium motivate its potential in this field of therapeutics aimed at improving fracture healing.
Important limitations related to the study design restrict the applicability of the lithium regimen prior to further evaluation. Femoral shaft fracture is a standard fracture model in pre-clinical animal studies, however the diaphysis consists of predominantly cortical bone. More commonly, prevalent fracture locations in osteoporotic patients that often include trabecular bone, that is, periarticular/metaphyseal injury sites (proximal humerus, distal radius, and vertebrae) were not evaluated. The osteoporosis model utilized herein is representative of the bone reduction seen post menopause rather than the established state of aged bone in elderly patients. Thus, direct correlation of improved fracture healing in osteoporosis induced by other states than estrogen deficiency may not be applicable.
As our population ages the incidence of osteoporotic fractures is rising. Predictable and expedited fracture healing is critical for these patients. This study demonstrated a translatable lithium regimen that enhances the healing of osteoporotic shaft fractures and, in a broader sense, demonstrated lithium's potential to aid healing even under impaired bone conditions. As a simple, short course oral treatment, lithium may represent a much needed adjunct to reduce the burden of impaired bone fracture management.
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